Zentek (TSXV:ZEN) Receivables Turnover : 0.00 (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Zentek Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Zentek's Revenue for the three months ended in Dec. 2024 was C$0.04 Mil. Zentek's average Accounts Receivable for the three months ended in Dec. 2024 was C$0.00 Mil.

Zentek Receivables Turnover Historical Data

The historical data trend for Zentek's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentek Receivables Turnover Chart

Zentek Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Receivables Turnover

Get a 7-Day Free Trial

1.08

0.46

8.57

Zentek Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Receivables Turnover	Get a 7-Day Free Trial															0.16	0.24	5.00	-	-

Competitive Comparison of Zentek's Receivables Turnover

For the Medical Instruments & Supplies subindustry, Zentek's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zentek's Receivables Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zentek's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Zentek's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Zentek Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Zentek's Receivables Turnover for the fiscal year that ended in Mar. 2024 is calculated as

	Receivables Turnover (A: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Mar. 2024 )	/ (	(Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )
=	0.03	/ (	(0.006	+	0.001)	/	2 )
=	0.03	/	0.0035
=	8.57

Zentek's Receivables Turnover for the quarter that ended in Dec. 2024 is calculated as

	Receivables Turnover (Q: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2024 )	/ (	(Accounts Receivable (Q: Sep. 2024 )	+	Accounts Receivable (Q: Dec. 2024 ))	/	count )
=	0.038	/ (	(0	+	0)	/	1 )
=	0.038	/	0
=	N/A

Zentek (TSXV:ZEN) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Zentek Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Zentek's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Zentek Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (TSXV:ZEN) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

ZTEK:USA ZAY:Germany

Address

24 Corporate Court, Guelph, ON, CAN, N1G 5G5

Website

https://www.zentek.com

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Executives

Colin Stuart Van Der Kuur	Senior Officer
Francis Jacques Dubé	Director
Ilse Treurnicht	Director
John Snisarenko	Director
Brian Gerald Bosse	Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Gregory Fenton	Director
Eric Wallman	Director